Invention Grant
- Patent Title: Compounds for targeted degradation of BRD9
-
Application No.: US17541035Application Date: 2021-12-02
-
Publication No.: US11691972B2Publication Date: 2023-07-04
- Inventor: Christopher G. Nasveschuk , Rhamy Zeid , Ning Yin , Katrina L. Jackson , Gesine Kerstin Veits , Moses Moustakim , Jeremy L. Yap
- Applicant: C4 Therapeutics, Inc.
- Applicant Address: US MA Watertown
- Assignee: C4 Therapeutics, Inc.
- Current Assignee: C4 Therapeutics, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Knowles Intellectual Property Strategies, LLC
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D401/14 ; A61P35/00
Abstract:
A BRD9 protein degrading compound of structure
or a pharmaceutically acceptable salt thereof is provided for the treatment of a disorder mediated by BRD9, including but not limited to abnormal cellular proliferation including cancer.
or a pharmaceutically acceptable salt thereof is provided for the treatment of a disorder mediated by BRD9, including but not limited to abnormal cellular proliferation including cancer.
Public/Granted literature
- US20220098194A1 COMPOUNDS FOR TARGETED DEGRADATION OF BRD9 Public/Granted day:2022-03-31
Information query
